| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/04/2007 | CN1939431A Medicine for treating prostatic accrementition |
| 04/04/2007 | CN1939429A Drop pills for treating inflammation and preparation thereof |
| 04/04/2007 | CN1939422A Health-care medicated liquor with kidney-yang tonifying function |
| 04/04/2007 | CN1939410A Musk medicinal preparation |
| 04/04/2007 | CN1939378A Preparation of blood-activating and pain-stopping capsules |
| 04/04/2007 | CN1939365A Cell-repairing oral liquid |
| 04/04/2007 | CN1939354A Medicine for treating burn and scald |
| 04/04/2007 | CN1939347A Chinese medicine extract, its production and use in pharmacy |
| 04/04/2007 | CN1939346A Slug polysaccharide and its making method |
| 04/04/2007 | CN1939345A American falx extract, medicinal composition containing it and its making method |
| 04/04/2007 | CN1939344A Donkey-hide gelatin oral preparation and its making method |
| 04/04/2007 | CN1939343A Bone-peptide sodium chloride injection and its making method |
| 04/04/2007 | CN1939342A Injection bone peptide freeze-drying preparation and its making method |
| 04/04/2007 | CN1939341A Brain protein hydrolyte freeze-drying preparation for injection and its making method |
| 04/04/2007 | CN1308450C Methods and compositions for diagnosis and treatment of cancer |
| 04/04/2007 | CN1308438C Compositions including ammonia oxidizing bacteria and methods of using same |
| 04/04/2007 | CN1308436C Lactic acid producing bacteria for use as probiotic organisms in the human vagina |
| 04/04/2007 | CN1308027C Medicinal formulation for treating skin tinea |
| 04/04/2007 | CN1308022C Chinese medicinal oral liquid for preventing and treating apoplexy sequelae |
| 04/04/2007 | CN1308020C Chinese medicinal composition for treating psoriasis |
| 04/04/2007 | CN1308016C Tonic wine |
| 04/04/2007 | CN1308013C Health care capsule for improving sleeping |
| 04/04/2007 | CN1308012C Chinese medicine composition for treating cerebral hemorrhage and its preparation process |
| 04/04/2007 | CN1308009C Health care product having blood pressure regulating function |
| 04/04/2007 | CN1308008C Pharmaceutical composition for treating coronary heart disease |
| 04/04/2007 | CN1307999C Mixed-cell gene therapy |
| 04/04/2007 | CN1307977C Propolis dripping pills for treating toothache and its preparation method |
| 04/04/2007 | CN1307972C Stomachache treating Chinese medicine |
| 04/03/2007 | USRE39542 Preparation of agarose coated, solid agarose-collagen beads containing secretory cells |
| 04/03/2007 | US7199234 Nucleotide sequences coding telomerase reverse transcriptase (TRT) for diagnosing and treating cancers; antiproliferative agents |
| 04/03/2007 | US7199223 Water soluble polyoxyethylene glylcol polyvinylpyrrolidone, polyvinyl alcohol, polyoxazoline, and/or polyacryloylmorpholine, conjugated to antihemophilic factor |
| 04/03/2007 | US7199161 Clusianon derivatives; anticarcinogenic, antitumor and viricidal agents; mixture with mitogen-activated protein (MAP) kinase inhibitors |
| 04/03/2007 | US7199151 DHA-pharmaceutical agent conjugates of taxanes |
| 04/03/2007 | US7198951 Viral expression vector for use as heterologous gene and/or therapeutic protein delivery tools; genetic vaccine |
| 04/03/2007 | US7198950 Self-inactivating plasmid/vector; gene therapy; treating hematological disorders; anticarcinogenic agents |
| 04/03/2007 | US7198934 Genetic engineering; gene insertion; culture product |
| 04/03/2007 | US7198920 HER-2/neu fusion proteins |
| 04/03/2007 | US7198909 Myeloid precursor cell useful for gene therapy and for modulation of immune responses |
| 04/03/2007 | US7198790 Growth differentiation factor-5 |
| 04/03/2007 | US7198785 Systems and methods related to degradation of uremic toxins |
| 04/03/2007 | US7198783 Sensitization of neoplastic cells to radiation therapy with reovirus |
| 04/03/2007 | US7198641 Scaffolds for tissue engineered hair |
| 04/03/2007 | US7198254 System for producing micro-cluster liquids |
| 04/03/2007 | CA2432552C Biological fluid processing |
| 04/03/2007 | CA2238295C Complementary adenoviral vector systems and cell lines |
| 04/03/2007 | CA2162397C Ligands for flt3 receptors |
| 03/29/2007 | WO2007035843A2 Methods and compositions for organ and tissue functionality |
| 03/29/2007 | WO2007035634A2 Device and method for hair growth from stem cells |
| 03/29/2007 | WO2007035583A1 Lyophilization of hemoglobin solutions |
| 03/29/2007 | WO2007035363A2 Compositions and methods for the augmentation and repair of defects in tissue |
| 03/29/2007 | WO2007035129A1 Preparation for treating non-infectious inflammatory intestinal diseases |
| 03/29/2007 | WO2007035057A1 Composition for preventing or treating artritis comprising lactic acid bacteria and collangen as active ingredients |
| 03/29/2007 | WO2007034948A1 Method of inhibiting the proliferation and migration of helicobacter pylori |
| 03/29/2007 | WO2007034927A1 Medicine, food and drink or feed containing sphingomyelin |
| 03/29/2007 | WO2007034219A2 Modifying leukocyte function |
| 03/29/2007 | WO2007033533A1 Use of nocardia rubra cell wall skeleton to produce medicaments for resisting human papilloma virus hpv |
| 03/29/2007 | WO2006113475A3 Methods and compositions to modulate adhesion and stress tolerance in bacteria |
| 03/29/2007 | WO2006112714A3 Uronic acid and probiotics |
| 03/29/2007 | WO2006067419A3 Myrtaceous honey and the use thereof as immunomodulator |
| 03/29/2007 | WO2005042723A3 Novel multipotent stem cells and use thereof |
| 03/29/2007 | US20070072794 Novel genes and proteins encoded thereby |
| 03/29/2007 | US20070072291 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 03/29/2007 | US20070071830 Method for increasing bioavailability of lipophilic bioactive compounds |
| 03/29/2007 | US20070071829 Universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma |
| 03/29/2007 | US20070071828 Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment |
| 03/29/2007 | US20070071808 Capsule filled with honey |
| 03/29/2007 | US20070071791 Delivery system for bone growth promoting material |
| 03/29/2007 | US20070071771 Method for limiting the growth of cancer cells using an attenuated measles virus |
| 03/29/2007 | US20070071770 Recombinant MVA virus, and the use thereof |
| 03/29/2007 | US20070071769 Recombinant MVA virus, and the use thereof |
| 03/29/2007 | US20070071765 Compositions for Immunotherapy and Uses Thereof |
| 03/29/2007 | US20070071738 Propionibacterium P-63 for use in direct fed microbials for animal feeds |
| 03/29/2007 | US20070071737 Live bacterium preparation containing lactic acid bacterium as active ingredient and food containing lactic acid bacterium |
| 03/29/2007 | US20070071736 Propagating stem cells in growth factor mixture at preferential site in heart; tissue engineering; regenerative medicine |
| 03/29/2007 | US20070071735 Propagating stem cells in growth factor mixture at preferential site in heart; tissue engineering; regenerative medicine |
| 03/29/2007 | US20070071733 Synthetic substrate for tissue formation |
| 03/29/2007 | US20070071732 Secretory cell-containing macrobeads comprising seakem gold agarose, and uses thereof |
| 03/29/2007 | US20070071731 Promotion Of Neurogenesis Of Endogenous And Transplanted Human Neural Stem Cells |
| 03/29/2007 | US20070071730 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 03/29/2007 | US20070071729 Dermal fillers for biomedical applications in mammals and methods of using the same |
| 03/29/2007 | US20070071728 Biomimetic nanocomposite |
| 03/29/2007 | US20070071727 Melanocytes in therapy of neurodegenerative diseases |
| 03/29/2007 | US20070071723 In Vivo Enhancement of Immune System Recognition of Neoplasms Following Treatment with an Oncolytic Virus or Gene Therapy Vector |
| 03/29/2007 | CA2623590A1 A preparation for treatment of non-infectious inflammatory intestinal diseases |
| 03/29/2007 | CA2623304A1 Medicine, food and drink or feed containing sphingomyelin |
| 03/29/2007 | CA2622869A1 Modifying leukocyte function |
| 03/28/2007 | EP1767642A1 Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof |
| 03/28/2007 | EP1767636A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 03/28/2007 | EP1767619A1 Method of culturing embryonic stem cells with the use of amniotic membrane-origin factor |
| 03/28/2007 | EP1766389A1 A method of cell isolation |
| 03/28/2007 | EP1766388A2 Stable isotope labeled polypeptide standards for protein quantitation |
| 03/28/2007 | EP1765989A2 Therapeutic delivery of adenosine into a tissue |
| 03/28/2007 | EP1765985A2 Methods and compositions for producing germ cells from peripheral blood derived germline stem cells |
| 03/28/2007 | EP1765983A2 Methods and compositions for producing germ cells from bone marrow derived germline stem cells |
| 03/28/2007 | EP1765981A1 Tissue material and muscle derived matrix |
| 03/28/2007 | EP1765975A1 Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries |
| 03/28/2007 | EP1765391A1 Bacterial compositions for the treatment of cancer |
| 03/28/2007 | EP1765381A1 Treatment of neurological disorders with haematopoietic growth factors |
| 03/28/2007 | EP1765370A1 Parapoxviruses in combination with other antiviral agents for the treatment of hiv/aids |
| 03/28/2007 | EP1765202A2 Periosteal distraction |